Kneat.com (KSI) Q3 2024 earnings summary

Executive summary

• Achieved record third-quarter revenue of CAD 12.8 million, up 52% year-over-year, and gross profit of CAD 9.8 million, up 78% year-over-year.

• Annual recurring revenue (ARR) reached CAD 49.9 million at quarter-end, a 59% increase year-over-year.

• Net income for Q3 2024 was CAD 1.2 million, compared to a net loss of CAD 3.6 million in Q3 2023.

• Signed major multi-year agreements with global pharmaceutical and medical device companies to digitize validation processes.

• Strategic goals include expanding within current customers, gaining market share, strengthening the platform, and progressing toward profitability.

Financial highlights

• SaaS revenue for Q3 2024 grew 48% year-over-year to CAD 11.5 million; ARR from SaaS licenses reached CAD 49.7 million, up 59%.

• Professional services revenue grew 90% year-over-year in Q3, reflecting milestone achievements.

• Gross margin for Q3 reached a record 77%, up from 65% in Q3 2023.

• Year-to-date revenue rose 44% to CAD 35.2 million, with SaaS revenue at CAD 32 million, up 51%.

• Adjusted EBITDA for Q3 2024 was CAD 2.9 million, up from $(0.5) million in Q3 2023.

Outlook and guidance

• Strong pipeline expected to deliver continued ARR and revenue growth in Q4.

• Management expects continued SaaS sales expansion, greater platform efficiencies, and increased optionality following recent funding.

• Additional investment anticipated in R&D, go-to-market, customer success, and support in 2025, funded by recent equity raise.

• Focus remains on disciplined investment and leveraging past investments for future growth.

• Positioned for further growth and profitability with strengthened balance sheet and new strategic customers.